The presence of systemic anti GM-CSF antibodies in idiopathic PAP led to the hypothesis that PAP could be an autoimmune disease and hence the rationale for plasmapheresis as a therapeutic option. The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.